BD PhaSeal™ Evidence

BD PhaSeal™ System:  Evidence-Based Performance

As of January 2012, BD PhaSeal has more clinical studies published than any other closed-system drug transfer device. The effectiveness of BD PhaSeal has been studied and validated by 19 independent, peer-reviewed, published studies. Several of these independent studies conducted by thought leaders at leading medical facilities and universities across the globe demonstrate that BD PhaSeal meets the NIOSH and ISOPP definition of a closed system transfer device (CSTD):

“a drug transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug or vapor concentrations outside the system.”

The BD PhaSeal System’s unique features, such as dry, leakproof connections and an airtight expansion chamber, have been validated by these numerous studies. A recently conducted study has also shown its ability to provide a barrier to the entry of contaminants into sterile solutions.*

View the bibliography of studies

Safety Guidelines

Guidelines on the safe handling of hazardous drugs have been written to protect healthcare workers and the environment. Visit the Guidelines page to view guidelines that address alerts such as this one:

NIOSH ALERT: National Institute of Occupational Safety and Health, 2004

* McMichael D, Jefferson D, Carey E et al. Utility of the PhaSeal closed system drug transfer device. The American Journal of Pharmacy Benefits. 2011; 3(1): 9-16.

P463  02/12